Bromodomain-Selective BET Inhibitors Are Potent Antitumor Agents against MYC-Driven Pediatric CancerP.J. Slavish, Philip M. Potter, Geoffrey Neale et al.|Cancer Research|2020Cited by 43
Supplementary Data from Bromodomain-Selective BET Inhibitors Are Potent Antitumor Agents against MYC-Driven Pediatric CancerP.J. Slavish, Philip M. Potter, Liying Chi et al.|Unknown|2023Cited by 0
Data from Bromodomain-Selective BET Inhibitors Are Potent Antitumor Agents against MYC-Driven Pediatric CancerP.J. Slavish, Philip M. Potter, Liying Chi et al.|Unknown|2023Cited by 0
Supplementary Data from Bromodomain-Selective BET Inhibitors Are Potent Antitumor Agents against MYC-Driven Pediatric CancerP.J. Slavish, Philip M. Potter, Liying Chi et al.|Unknown|2023Cited by 0
Data from Bromodomain-Selective BET Inhibitors Are Potent Antitumor Agents against MYC-Driven Pediatric CancerP.J. Slavish, Philip M. Potter, Liying Chi et al.|Unknown|2023Cited by 0